← Leaderboards
Chandrika J Piyathilake
University Of Alabama At Birmingham
$5,634,935
Attributed
$5,634,935
Total exposure
9
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $974.3K · FY2005–15$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$5,634,935 · 9
By mechanism
R01$4,340,765 · 2
R21$692,641 · 2
R03$358,405 · 3
K07$173,111 · 1
U54$70,013 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- William E. Grizzle$27,727,915
- Gary L Johanning$1,496,692
- Huang-Ge Zhang$11,876,098
- Ralph R Weichselbaum$16,065,057
- Alan Kenneth Percy$11,873,575
Others in their field
Top investigators on “Folate”
- Paul M. Ridker · Brigham And Women'S Hospital$55,416,022
- Brian E Henderson · University Of Southern California$20,353,887
- Ulrike Peters · Fred Hutchinson Cancer Research Center$18,907,654
- James F Toole · Wake Forest University Health Sciences$17,951,480
- John Anthony Baron · Dartmouth College$17,250,532
- Loic Le Marchand · University Of Hawaii At Manoa$17,180,480
Research focus
FolateDna MethylationMalignant NeoplasmsMalignant Neoplasm Of Cervix UteriCellsDiagnosisCervicalWomanCervical Intraepithelial NeoplasiaCancer RiskCarcinogenesisInfectionLesionHuman PapillomavirusSmokingHpv-High RiskMethylationVitaminsHuman Papillomavirus 16Folic AcidPreventionBiomarkerBaseCost
Grant awards (21)
Microbiome based Approach to Identify the Progression Potential of CIN 2 lesions$159,863
R21 · FY2015 · CA · contact PI
Microbiome based Approach to Identify the Progression Potential of CIN 2 lesions$191,835
R21 · FY2014 · CA · contact PI
Cervical Cancer Preventive Measures Based on HPV 16 Epigenome$149,760
R21 · FY2013 · CA · contact PI
Cervical Cancer Preventive Measures Based on HPV 16 Epigenome$191,183
R21 · FY2012 · CA · contact PI
HPV Clearance by Folic Acid Supplementation$482,688
R01 · FY2010 · CA · contact PI
HPV Clearance by Folic Acid Supplementation$473,364
R01 · FY2009 · CA · contact PI
HPV Clearance by Folic Acid Supplementation$480,321
R01 · FY2008 · CA · contact PI
Prognostic Significance of DNA and Histone Methylation$501,794
R01 · FY2007 · CA · contact PI
HPV Clearance by Folic Acid Supplementation$455,315
R01 · FY2007 · CA · contact PI
HPV Clearance by Folic Acid Supplementation$489,446
R01 · FY2006 · CA · contact PI
Prognostic Significance of DNA & Histone Methylation$484,823
R01 · FY2006 · CA · contact PI
Prognostic Significance of DNA &Histone Methylation$484,722
R01 · FY2005 · CA
Effects of Folate Fortification on Cancer Prevention an*$72,500
R03 · FY2005 · CA
PILOT PROJECT 5$70,013
U54 · FY2005 · CA
Prognostic Significance of DNA and Histone Methylation$488,292
R01 · FY2004 · CA
Effects of Folate Fortification on Cancer Prevention$72,500
R03 · FY2004 · CA
Prognostic Significance of Altered DNA Methylation$71,641
R03 · FY2002 · CA
LOCALIZED VITAMIN DEFICIENCIES AND RISK FOR LUNG CANCER$85,825
K07 · FY2001 · CA
Prognostic Significance of Altered DNA Methylation$70,549
R03 · FY2001 · CA
LOCALIZED VITAMIN DEFICIENCIES AND RISK FOR LUNG CANCER$87,286
K07 · FY2000 · CA
GENETIC DIFFERENCES IN SUSCEPTIBILITY FOR LUNG CANCER$71,215
R03 · FY2000 · CA